Please assess the completion status of the following clinical trial:

Trial Title: Non-cutting Laser Therapy in the Treatment of Acne

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age 15 years or older of either gender and of any racial/ethnic group.~* Presence of clinically-evident facial acne.~* Subjects must be in generally good health.~* Subjects must be able and willing to comply with the requirements of the protocol.~* You must live within a reasonable driving distance of Ann Arbor, Michigan, and/or be able to attend all of the scheduled appointments during the study.~Exclusion Criteria:~* Oral retinoid (Accutane) use within 6 months of entry into the study.~* Systemic acne therapies (oral antibiotics) within 4 weeks of entry into the study.~* Topical acne therapies (retinoids, antibiotics) within 2 weeks of entry into the study.~* Microdermabrasion or superficial chemical peels at the sites to be treated within 2 months of entry into the study.~* Subjects with a history of dermabrasion or laser resurfacing at the sites to be treated.~* Use of topical lipid absorbing substances (Clinac AC) within 2 weeks of entry into the study.~* Non-compliant subjects.~* Subjects with a significant medical history or concurrent illness/condition which the investigator(s) feel is not safe for study participation.~* Subjects using alcohol-based topical solutions or exfoliating agents within 2 weeks of entry into the study.~* Subjects with a history of very frequent herpes simplex infections of the face or with clinical evidence of active herpes simplex infections.~* History of keloid (excessive scar) formation for subjects undergoing biopsies.~* Pregnant or nursing females.~* Subjects with known allergy or hypersensitivity to topical photosensitizing agents.~* Subjects with known photosensitivity disorders felt by the investigators to preclude safe inclusion in the study.

- Gender: ALL
- Minimum Age: 15 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Laser Therapy (Type: EXPERIMENTAL): V-Beam laser, Candela Corp., 595 nm wavelength
- Control (Type: NO_INTERVENTION): Untreated

Based on this trial design, predict the completion outcome and termination type (if applicable).